Overview

A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
An H3 receptor antagonist should reduce the congestion associated with allergic rhinitis. A nasal allergen challenge will be given to patients to induce rhinitis symptoms and acoustic rhinometry will be used to measure the congestion.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Fexofenadine
Terfenadine